Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-036271
Filing Date
2024-11-26
Accepted
2024-11-26 16:27:52
Documents
93
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A ctdh20231231c_10ka.htm   iXBRL 10-K/A 1627664
2 EXHIBIT 31.1 ex_752511.htm EX-31.1 13920
3 EXHIBIT 31.2 ex_752512.htm EX-31.2 13473
4 EXHIBIT 32.1 ex_752513.htm EX-32.1 4938
5 EXHIBIT 32.2 ex_752514.htm EX-32.2 4817
11 image01.jpg GRAPHIC 36495
12 image02.jpg GRAPHIC 116652
13 image03.jpg GRAPHIC 76941
14 image04.jpg GRAPHIC 53918
15 image05.jpg GRAPHIC 36054
  Complete submission text file 0001437749-24-036271.txt   8728758

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20231231.xsd EX-101.SCH 83211
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20231231_def.xml EX-101.DEF 541522
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20231231_lab.xml EX-101.LAB 457002
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20231231_pre.xml EX-101.PRE 579580
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctdh-20231231_cal.xml EX-101.CAL 54439
96 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20231231c_10ka_htm.xml XML 1038947
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

EIN.: 593029743 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39780 | Film No.: 241504327
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)